Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) said shareholders will vote on transferring SAR 67.13 million from the statutory reserve to retained earnings during an extraordinary general meeting scheduled for June 15. 
In a statement to Tadawul, the company said the amount was recorded in the annual financial statements for 2025.
Shareholders will also vote on authorizing the board to distribute interim dividends for 2026 on a semiannual or quarterly basis, the company added.
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) said shareholders will vote on transferring SAR 67.13 million from the statutory reserve to retained earnings during an extraordinary general meeting scheduled for June 15.
In a statement to Tadawul, the company said the amount was recorded in the annual financial statements for 2025.
Shareholders will also vote on authorizing the board to distribute interim dividends for 2026 on a semiannual or quarterly basis, the company added.
